Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?
January 08, 2024
Tickers
CYTK
NEWS
NVS
Tags
NVS
CYTK
Eurasia
From
Benzinga
Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?
January 08, 2024
Tickers
EXEL
MRK
NEWS
NVS
Tags
Trading Ideas
Analyst Color
EXEL
From
Benzinga
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery
January 08, 2024
Tickers
GOOG
GOOGL
LLY
NEWS
Tags
AI Generated
News
Briefs
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
January 05, 2024
Tickers
NVS
Tags
Short Ideas
Market News
BZI/SHORTHIST
From
Benzinga
Voyager Therapeutics Stock Tanked After-Hours - Here's Why
January 04, 2024
Tickers
NEWS
NVS
VYGR
Tags
Small Cap
Market News
why it's moving
From
Benzinga
Big Players' Recent Trades in NVS Options
January 04, 2024
Tickers
NVS
Tags
Market News
Markets
BZI/UOA
From
Benzinga
VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today
January 02, 2024
Tickers
AZN
NBIX
NVS
VYGR
Tags
NVS
NBIX
AZN
From
InvestorPlace
Why Is Gene Therapy Focused Voyager Therapeutics Stock Soaring Today?
January 02, 2024
Tickers
NEWS
NVS
VYGR
Tags
News
Large Cap
Briefs
From
Benzinga
Why Is Neurology Focused Cingulate Stock Trading Higher Today?
December 28, 2023
Tickers
CING
NEWS
NVS
Tags
Trading Ideas
NVS
Market News
From
Benzinga
Why Is Cytokinetics (CYTK) Stock Up 70% Today?
December 27, 2023
Tickers
AZN
BMY
CYTK
NVS
Tags
CYTK
Today's Market
BMY
From
InvestorPlace
These 3 Big Pharma Stocks Are Making Big Plays With AI
December 22, 2023
Tickers
AZN
LLY
NVS
Tags
AZN
Market News
Recent Press Releases
From
Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Tickers
CALT
MCK
NVS
RHHBY
Tags
Expert Ideas
RHHBY
Health Care
From
Benzinga
Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
December 20, 2023
Tickers
AZN
FUSN
NVS
Tags
NVS
FUSN
Trading Ideas
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 20, 2023
Tickers
NVS
Tags
Short Ideas
Market News
BZI/SHORTHIST
From
Benzinga
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
December 19, 2023
Tickers
LNTH
NVS
PNT
Tags
Benzinga
General
News
From
Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
Tickers
ECX
FSR
FTRE
GELYF
Tags
MZDAY
STLA
Hot Stocks
From
InvestorPlace
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Tickers
MRK
NVS
Tags
MRK
Health Care
Market News
From
Benzinga
Novartis' Newly FDA-Approved Rare Blood Disorder Drug Aces Phase 3 Study In Ultra Rare Kidney Failure Disease
December 11, 2023
Tickers
NVS
Tags
Eurasia
Equities
Biotech
From
Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
Tickers
BMY
GILD
NVS
Tags
NVS
BMY
Market News
From
Motley Fool
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Tickers
NVS
Tags
Health Care
Market News
Biotech
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Tickers
NVS
Tags
Benzinga
NVS
Short Sellers
From
Benzinga
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
Tickers
BMY
GILD
JNJ
NVS
Tags
Expert Ideas
Health Care
JNJ
From
Benzinga
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
November 28, 2023
Tickers
BMY
CABA
GILD
GRCL
Tags
CABA
BMY
NVS
From
MarketWatch
3 Healthcare Stocks to Pick Up Before the Year-End Rally
November 28, 2023
Tickers
BSX
NVS
UNH
Tags
Stocks to Buy
UNH
Market News
From
InvestorPlace
Novartis Outlines Pure-Play Strategy Progress After Generics Business Spin-Off
November 28, 2023
Tickers
NVS
Tags
General
Briefs
News
From
Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
November 16, 2023
Tickers
CVRX
JNJ
LEGN
NVS
Tags
Market News
Recent Press Releases
PTGX
From
Motley Fool
Verve Therapeutics’ stock falls 40% as analysts question safety of cholesterol-cutting gene-editing treatment
November 13, 2023
Tickers
BEAM
LLY
NVS
SPX
Tags
LLY
NVS
SPX
From
MarketWatch
How Is The Market Feeling About Novartis?
November 10, 2023
Tickers
NVS
Tags
Short Sellers
NVS
Benzinga
From
Benzinga
3 Spectacular High-Yield Dividend Stocks to Buy in November
November 05, 2023
Tickers
ABBV
NVS
PFE
Tags
NVS
Market News
Recent Press Releases
From
Motley Fool
Novartis' Rare Kidney Disease Candidate Aces Late-Stage Study
October 30, 2023
Tickers
NVS
Tags
Benzinga
NVS
Large Cap
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.